Sugi Predict

Sugi Predict / Compounds / SCHEMBL1448259

SCHEMBL1448259

SCHEMBL1448259

O=C(O)c1cc([N+](=O)[O-])cc(F)c1Br

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 5/20 0.44
▸ MAPT P10636 3/20 0.44
▸ TDP1 Q9NUW8 2/20 0.44
▸ CYP3A4 P08684 1/20 0.44
▸ ALOX15 P16050 1/20 0.44
▸ MAPK1 P28482 1/20 0.43
▸ LMNA P02545 2/20 0.42
▸ KMT2A Q03164 2/20 0.41
▸ MEN1 O00255 1/20 0.41
▸ AKR1C2 P52895 1/20 0.41
▸ AKR1C1 Q04828 1/20 0.41
▸ TP53 P04637 1/20 0.41
▸ HTT P42858 1/20 0.41
▸ CTSV O60911 1/20 0.41
▸ CTSL P07711 1/20 0.41
▸ HIF1A Q16665 1/20 0.41
▸ SMN1; SMN2 Q16637 1/20 0.40
▸ CA1 P00915 1/20 0.40
▸ CA2 P00918 1/20 0.40
▸ DTYMK P23919 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29743769 1.00 ALDH1A1 (0.44) ALDH1A1MAPTTDP1CYP3A4ALOX15
SCHEMBL8841205 0.87 ALDH1A1 (0.50) ALDH1A1MAPTTDP1CYP3A4ALOX15
SCHEMBL12548246 0.85 MAPT (0.44) ALDH1A1MAPTCYP3A4MAPK1LMNA
SCHEMBL1740988 0.82 ALDH1A1 (0.46) ALDH1A1MAPTTDP1CYP3A4ALOX15
SCHEMBL29310309 0.81 CYP19A1 (0.48) ALDH1A1MAPTTDP1CYP3A4ALOX15
SCHEMBL1448201 0.81 ALDH1A1 (0.43) ALDH1A1MAPTLMNAKMT2AMEN1
SCHEMBL13338213 0.81 ALDH1A1 (0.56) ALDH1A1MAPTTDP1CYP3A4ALOX15
SCHEMBL20298758 0.81 ALDH1A1 (0.49) ALDH1A1MAPTTDP1CYP3A4ALOX15
SCHEMBL25287029 0.79 ALDH1A1 (0.44) ALDH1A1MAPTTDP1CYP3A4ALOX15
SCHEMBL1099320 0.79 ALDH1A1 (0.47) ALDH1A1MAPTTDP1CYP3A4ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 61 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119731169-A Sodium channel regulator and application thereof 上海汇伦医药股份有限公司 2025-03-28 — — CN disclosed
US-12239630-B2 Carboxylic acid aromatic amides as antagonists of bradykinin B1 receptor BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2025-03-04 — — US disclosed
CN-115068468-B Carboxylic aromatic amides as bradykinin B1 receptor antagonists 拜耳制药股份公司 2025-02-25 — — CN disclosed
CN-115137726-B Carboxylic aromatic amides as bradykinin B1 receptor antagonists 拜耳制药股份公司 2024-08-13 — — CN disclosed
US-12023319-B2 Carboxylic acid aromatic amides BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2024-07-02 — — US disclosed
US-12023319-B2 Carboxylic acid aromatic amides BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2024-07-02 — — US disclosed
WO-2024046253-A1 SODIUM CHANNEL REGULATOR AND USE THEREOF 上海汇伦医药股份有限公司 2024-03-07 — — WO disclosed
US-11905270-B2 Carboxylic acid aromatic amides as antagonists of bradykinin B1 receptor BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2024-02-20 — — US disclosed
CN-115073421-B Carboxylic aromatic amides as bradykinin B1 receptor antagonists 拜耳制药股份公司 2023-12-19 — — CN disclosed
US-11827657-B2 Boron containing pyrazole compounds, compositions comprising them, methods and uses thereof Boehringer Ingelheim Animal Health USA Inc. (US) 2023-11-28 — — US disclosed
US-20100041664-A1 BICYCLIC LACTAM FACTOR VIIA INHIBITORS USEFUL AS ANTICOAGULANTS BRISTOL-MYERS SQUIBB COMPANY 2010-02-18 — — US disclosed
EP-2062050-A2 MODULATION OF CHEMOSENSORY RECEPTORS AND LIGANDS ASSOCIATED THEREWITH Senomyx, Inc. (US) 2009-05-27 — — EP disclosed
WO-2008154221-A2 MODULATION OF CHEMOSENSORY RECEPTORS AND LIGANDS ASSOCIATED THEREWITH SENOMYX, INC. (US) 2008-12-18 — — WO disclosed
US-20080293708-A1 Pyrimidine Derivatives NOVARTIS AG (CH) 2008-11-27 — — US disclosed
US-20080293708-A1 Pyrimidine Derivatives NOVARTIS AG (CH) 2008-11-27 — — US disclosed
US-20080293708-A1 Pyrimidine Derivatives NOVARTIS AG (CH) 2008-11-27 — — US disclosed
WO-2008079759-A1 BICYCLIC LACTAM FACTOR VIIA INHIBITORS USEFUL AS ANTICOAGULANTS BRISTOL-MYERS SQUIBB COMPANY (US) 2008-07-03 — — WO disclosed
CN-101006079-A Pyrimidine derivatives NOVARTIS AG (CH) 2007-07-25 — — CN disclosed
EP-1784399-A2 PYRIMIDINE DERIVATIVES Novartis AG (CH) 2007-05-16 — — EP disclosed
WO-2006021457-A2 PYRIMIDINE DERIVATIVES NOVARTIS AG (CH) 2006-03-02 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11905270-B2 Carboxylic acid aromatic amides as antagonists of bradykinin B1 receptor BDKRB1, BDKRB2, HCAR1 ALDH1A1 834/4885MAPT 1489/4885TDP1 3200/4885
US-11827657-B2 Boron containing pyrazole compounds, compositions comprising them, methods and uses thereof JAK3, JAK1, JAK2 ALDH1A1 3977/4885MAPT 2548/4885TDP1 1739/4885
US-12023319-B2 Carboxylic acid aromatic amides DDC, PAH, NAT1 ALDH1A1 135/4885MAPT 674/4885TDP1 2302/4885
US-20100041664-A1 BICYCLIC LACTAM FACTOR VIIA INHIBITORS USEFUL AS ANTICOAGULANTS F7, F8, F9 ALDH1A1 4405/4885MAPT 3493/4885TDP1 3824/4885
US-12239630-B2 Carboxylic acid aromatic amides as antagonists of bradykinin B1 receptor BDKRB1, BDKRB2, HCAR1 ALDH1A1 861/4885MAPT 1550/4885TDP1 3452/4885
US-20080293708-A1 Pyrimidine Derivatives DPYD, TYMP, TYMS ALDH1A1 955/4885MAPT 2574/4885TDP1 334/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.